AMP Limited’s Net Profit fell 74% due to misconduct inquiry

AMP Ltd

In line Financial Performance for 1H 2018: AMP Limited’s (ASX: AMP) stock rose 4.48% on August 8, 2018 (before market close) after the company delivered 5.7% growth in underlying profit due to cost cutting for 1H 2018. However, AMP for the first half reported 74% fall in the net profit to A$115 million as  the company set aside cash to compensate customers it sold bad advice, and said that people are still withdrawing money on the back of a misconduct inquiry during the Royal Commission. The 74% fall in the profit is in line with the analysts’ expectation, and represented resilient performance despite Royal Commission impact. Moreover, for 1H 2018, AMP Bank’s earnings grew 20 per cent on 1H 17.

[optin-monster-shortcode id=”wxhmli4jjedneglg1trq”]

There is continued momentum in AMP Capital with operating earnings up 2 per cent on 1H 17 during period on the back of investment in real assets capability and international expansion. Australian wealth management was resilient in a challenging environment as for 1H 2018, the segment’s operating earnings increased 6 per cent to A$204 million and assets under management increased 6 per cent to A$132 billion. Australian wealth protection profit margins were down to A$46 million compared to A$49 million in 1H 17, and the operating earnings witnessed decline to A$1 million due to higher than expected claims activity and reserve strengthening on a large terminated group plan. Further, AMP delivered strong performance on controllable costs due to 2017 business efficiency and restructure activities and is on track to at least achieve FY 18 cost guidance. Additionally, AMP is targeting total FY 18 dividend payout at lower end of 70%-90% guidance range. As a result, AMP stock has fallen 18.69% in three months as on August 07, 2018 and is trading at a P/E of 11.77x.

image !!

1H 18 Financial Performance (Source: Company Reports)

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Checkout our Free Dividend Stocks Report

Specially made for income-hungry investors, Invest in growing Franked Dividends an opportunity that should not be missed.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report